Call us : USA : 1-631-381-2994; Europe : 44-207-097-1828
Mail us : info@creative-biolabs.com
Creative Biolabs Blog

Menu

Skip to content
  • Drug Discovery Research
  • Immunotherapy Research
  • Antibody Engineering Research

Category Archives: Immunotherapy Research

Multivalent Single Domain Antibodies Help Block SARS-CoV-2 Infection and Suppress Mutational Escape

February 6, 2021Antibody Engineering Research, Immunotherapy ResearchAntibody Discovery, COVID-19, single domain antibodybiolabs

In a new study, an international team led by the University of Bonn identified and further developed the novel single-domain antibodies (sdAbs) against SARS-CoV-2. The researchers also combined these single-domain antibodies intoRead More…

Nat Methods: How to Enhance the Effect of T Cell Therapy?

January 8, 2021Immunotherapy Researchimmunotherapy, T cell receptorbiolabs

In a recent study, the scientists at UT Southwestern have developed a new method to study the molecular characteristics of T cells. The method, published on Nature Methods, makes it easier forRead More…

New TCR Therapy—Tebentafusp

December 10, 2020Immunotherapy Research, Newstcr, Therapeutic Antibodybiolabs

Recently, the phase 3 clinical trial results of T cell receptor (TCR) therapy, tebentafusp, have been released. The results showed that it reached the primary endpoint in the treatment of metastatic uvealRead More…

eLife: The New Anticancer Mechanism of T Cells

November 3, 2020Immunotherapy ResearchCAR-T, immunotherapybiolabs

A new study published on eLife shows when T cells in the immune system find and identify targets, they release chemicals to attract more T cells, and then gather to help suppressRead More…

What Are the Development Prospects & Anticancer Potential of CD38 Antibodies?

August 23, 2020Drug Discovery Research, Immunotherapy Researchimmunotherapy, monoclonal antibody, Therapeutic Antibodybiolabs

CD38 protein, which was discovered in 1980, is a type II transmembrane glycoprotein with a size of 46 kDa. The ligand of CD38 is CD31, also known as PECAM-1, which is aRead More…

Nature: Major Discovery! A Human Antibody Can Strongly Neutralize A Variety of Coronaviruses, including SARS-CoV and SARS-CoV-2

June 2, 2020Drug Discovery Research, Immunotherapy ResearchAntibody Discovery, COVID-19, SARS-CoV-2biolabs

In a new study, researchers from Humabs Biomed SA and the University of Washington found that an antibody that suppresses the associated coronavirus was identified for the first time in a bloodRead More…

Big News! Microbes Control the Health of the Immune System!

May 14, 2020Biological Knowledge, Immunotherapy Research, NewsConventional Dendriticcells, Immune System, immunotherapybiolabs

Researchers from Charité-Universitätsmedizin Berlin, Berlin Institute of Health and Deutsches Rheuma-Forschungszentrum, together with other scientists, have shown how microbes help the immune system respond to pathogens. Without the relevant mediators, the metabolicRead More…

Breakthrough! Scientists Have Successfully Reprogrammed T Cells to Improve the Efficacy of Cancer Immunotherapy

December 18, 2019Immunotherapy Researchcell therapy, immunotherapy, T cellbiolabs

In a study published in Nature, scientists from St. Jude’s Children’s Research Hospital and other institutions have developed a new treatment strategy to effectively enhance cancer immunotherapy, which may effectively slow tumorRead More…

Comprehensive Analysis of Targeted Drugs for Lung Cancer

October 11, 2019Drug Discovery Research, Immunotherapy Research, Newsimmunotherapy, monoclonal antibody, Small molecule targeted drugsbiolabs

Incidence of lung cancer Lung cancer has the highest incidence of cancer in the world. According to WHO’ statistics, there are an estimated 18.1 million new cancer patients worldwide in 2018, ofRead More…

How to Develop Immunotherapeutic Drugs?

August 6, 2019Drug Discovery Research, Immunotherapy ResearchCAR-T, immunotherapy, Therapeutic Antibodybiolabs

The high cost of cancer drugs makes it difficult for public and private health care systems to provide patients with up-to-date treatment. If this trend continues, it will be increasingly difficult forRead More…

Posts navigation

  • 1
  • 2
  • 3
  • 4
  • Next »

Categories

  • Antibody Engineering Research
  • Biological Knowledge
  • Drug Discovery Research
  • Immunotherapy Research
  • News

Recent Posts

  • CD47-related Signaling Pathways & Research Progress on the Relationship with Related Diseases (Part Three)
  • CD47-related Signaling Pathways & Research Progress on the Relationship with Related Diseases (Part Two)
  • CD47-related Signaling Pathways & Research Progress on the Relationship with Related Diseases (Part One)
  • Sci Rep: Monoclonal Antibody can Effectively Treat Malaria
  • Multivalent Single Domain Antibodies Help Block SARS-CoV-2 Infection and Suppress Mutational Escape

Archives

Contact Us

Address: USA – UK – Germany
Tel (USA): 1-631-381-2994
Tel (Europe): 44-207-097-1828
Fax: 1-631-207-8356
Email: info@creative-biolabs.com

Copyright © Creative Biolabs Blog
Powered by WordPress , Designed and Developed by templatesnext